Advertisement

Topics

EU green light for Shire’s pancreatic cancer drug Onivyde

06:11 EDT 19 Oct 2016 | PharmaTimes

The European Medicines Agency has now issued a green light for Shire's pancreatic therapy Onivyde, following its US approval in July this year.

Original Article: EU green light for Shire’s pancreatic cancer drug Onivyde

NEXT ARTICLE

More From BioPortfolio on "EU green light for Shire’s pancreatic cancer drug Onivyde"

Quick Search
Advertisement
 

Relevant Topic

Pancreatitis
Pancreatitis Acute pancreatitis is inflammation of the pancreas caused by the release of activated pancreatic enzymes. Common triggers are biliary tract disease and chronic heavy alcohol intake.  Diagnosis is based on clinical presentation...